Your browser doesn't support javascript.
loading
Putaminal Recombinant Glucocerebrosidase Delivery with Magnetic Resonance-Guided Focused Ultrasound in Parkinson's Disease: A Phase I Study.
Meng, Ying; Pople, Christopher B; Huang, Yuexi; Jones, Ryan M; Ottoy, Julie; Goubran, Maged; Oliveira, Lais M; Davidson, Benjamin; Lawrence, Liam S P; Lau, Angus Z; Bethune, Allison; Maralani, Pejman; Abrahao, Agessandro; Hamani, Clement; Hynynen, Kullervo; Kalia, Suneil K; Lipsman, Nir; Kalia, Lorraine V.
Afiliação
  • Meng Y; Division of Neurosurgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Pople CB; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Huang Y; Hurvitz Brain Sciences Research Program, Harquail Centre for Neuromodulation, Sunnybrook Research Institute, Toronto, Canada.
  • Jones RM; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Ottoy J; Hurvitz Brain Sciences Research Program, Harquail Centre for Neuromodulation, Sunnybrook Research Institute, Toronto, Canada.
  • Goubran M; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Oliveira LM; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Davidson B; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Lawrence LSP; Hurvitz Brain Sciences Research Program, Harquail Centre for Neuromodulation, Sunnybrook Research Institute, Toronto, Canada.
  • Lau AZ; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Bethune A; Hurvitz Brain Sciences Research Program, Harquail Centre for Neuromodulation, Sunnybrook Research Institute, Toronto, Canada.
  • Maralani P; Department of Medical Biophysics, University of Toronto, Toronto, Canada.
  • Abrahao A; Krembil Research Institute, University Health Network, University of Toronto, Toronto, Canada.
  • Hamani C; Division of Neurosurgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Hynynen K; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Kalia SK; Hurvitz Brain Sciences Research Program, Harquail Centre for Neuromodulation, Sunnybrook Research Institute, Toronto, Canada.
  • Lipsman N; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Kalia LV; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Mov Disord ; 37(10): 2134-2139, 2022 10.
Article em En | MEDLINE | ID: mdl-36089809
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Glucosilceramidase Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Glucosilceramidase Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article